,,使

Laura J Hsieh1, Tracy Lou2, Muryam A Gourdet3

  • 1Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA; TippingPoint Biosciences, Inc., San Francisco, CA 94107, USA; Lead Contacts, USA.

概括

这项研究引入了一种新的选方法,以识别针对疾病驱动性染色体状态的药物,通过将它们重建为相分离的冷凝物,减少非目标效应以获得更好的治疗转化.